scholarly article | Q13442814 |
P356 | DOI | 10.4269/AJTMH.2006.75.375 |
P698 | PubMed publication ID | 16968909 |
P50 | author | Grant Dorsey | Q60029509 |
Philip J Rosenthal | Q60060211 | ||
P2093 | author name string | Philip J Rosenthal | |
Arthur Reingold | |||
Grant Dorsey | |||
Jonathan Mermin | |||
Alan Hubbard | |||
Robert Downing | |||
Ben M Hunt | |||
Samuel S Malamba | |||
John R Lule | |||
Aminah Kigozi | |||
Ray Ransom | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
pyrimethamine | Q421072 | ||
P304 | page(s) | 375-380 | |
P577 | publication date | 2006-09-01 | |
P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
P1476 | title | Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members | |
P478 | volume | 75 |
Q36309128 | A cross-sectional study of sub-clinical Plasmodium falciparum infection in HIV-1 infected and uninfected populations in Mozambique, South-Eastern Africa |
Q53679268 | A man with unsuspected marine eosinophilic gastritis. |
Q34687538 | A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa |
Q28076750 | Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria? |
Q36896070 | Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough? |
Q37893776 | Consequences of HIV infection on malaria and therapeutic implications: a systematic review |
Q27009235 | Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis |
Q38843857 | Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial |
Q37116879 | Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA) |
Q37350124 | Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya |
Q36882506 | HIV treatments have malaria gametocyte killing and transmission blocking activity |
Q36759511 | Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review |
Q37333178 | In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation |
Q92840290 | Increased Frequency of Pfdhps A581G Mutation in Plasmodium falciparum Isolates from Gabonese HIV-Infected Individuals |
Q33834841 | Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau |
Q37260585 | Monitoring antifolate resistance in intermittent preventive therapy for malaria |
Q33817605 | Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus |
Q34736220 | Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics |
Q35960861 | Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda |
Q37131431 | Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial |
Q21133667 | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review |
Q36834927 | Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment |
Q38330997 | The expanding role of co-trimoxazole in developing countries |
Q64067248 | The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis |
Q30483555 | World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria |
Search more.